Supplement tables and figures for Associations between life-course body shape and sex hormone concentrations in men, pre- and postmenopausal women
Description
Supplemental Table 1. Trajectory modelling and model fit characteristics in men (HPFS), postmenopausal women (NHS+ NHS II) and premenopausal women (NHS+ NHS II). Supplemental Table 2. Sensitivity analysis on women who have never been exposed to hormone therapy. Percentage difference in biomarker levels between the reference group (the medium-stable group in postmenopausal women and the lean-stable/moderate group in premenopausal women) and the other trajectory groups in postmenopausal (NHS+ NHS II) and premenopausal women (NHS+ NHS II) Supplement Figure1. Flowchart of study participants. a) Of 3053 eligible men in the HPFS, 2431 were included in the final study. b) Of 7860 eligible women in the NHS study and 4517 in the NHS 2, 4801 premenopausal and 6018 postmenopausal women were included in the final study.